| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
110,773 |
103,042 |
$20.97M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
52,520 |
44,479 |
$108K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
7,074 |
6,547 |
$61K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
22,484 |
19,102 |
$51K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
864 |
794 |
$13K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,801 |
1,681 |
$12K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
8,279 |
7,199 |
$9K |
| 0011A |
|
200 |
200 |
$8K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,494 |
2,303 |
$8K |
| 0012A |
|
115 |
115 |
$7K |
| 90750 |
|
235 |
190 |
$7K |
| 90791 |
Psychiatric diagnostic evaluation |
2,134 |
1,859 |
$4K |
| 90746 |
|
145 |
125 |
$4K |
| 0064A |
|
106 |
105 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
634 |
509 |
$3K |
| 90832 |
Psychotherapy, 30 minutes with patient |
4,237 |
3,049 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,168 |
1,058 |
$2K |
| 90686 |
|
397 |
349 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
727 |
675 |
$2K |
| 90677 |
|
19 |
14 |
$2K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
124 |
107 |
$1K |
| 90715 |
|
107 |
90 |
$1K |
| 81002 |
|
9,166 |
8,055 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,224 |
3,778 |
$1K |
| 90707 |
|
40 |
32 |
$693.97 |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
507 |
448 |
$674.54 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
143 |
126 |
$619.55 |
| 90688 |
|
41 |
38 |
$549.88 |
| 3078F |
|
3,158 |
3,058 |
$540.27 |
| 81025 |
|
4,243 |
3,734 |
$533.22 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,921 |
1,702 |
$326.60 |
| 90732 |
|
19 |
16 |
$284.39 |
| 99385 |
|
14 |
13 |
$239.31 |
| 90651 |
|
50 |
42 |
$208.00 |
| 3080F |
|
35 |
33 |
$166.47 |
| 99201 |
|
40 |
34 |
$165.04 |
| 90734 |
|
21 |
19 |
$160.90 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,306 |
1,266 |
$150.45 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
47 |
41 |
$147.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,496 |
1,317 |
$79.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
14 |
14 |
$72.44 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
101 |
96 |
$30.12 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
133 |
129 |
$29.16 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
60 |
59 |
$20.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
424 |
406 |
$17.92 |
| 85018 |
|
26 |
25 |
$1.89 |
| 3077F |
|
263 |
254 |
$0.00 |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
15 |
15 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
871 |
855 |
$0.00 |
| 99173 |
|
54 |
45 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
12 |
12 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
14 |
14 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
24 |
21 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
29 |
27 |
$0.00 |
| 90658 |
|
13 |
12 |
$0.00 |
| 3074F |
|
3,675 |
3,555 |
$0.00 |
| 3075F |
|
447 |
439 |
$0.00 |
| 3079F |
|
953 |
923 |
$0.00 |
| 82962 |
|
109 |
92 |
$0.00 |
| 36416 |
|
13 |
13 |
$0.00 |
| 90656 |
|
32 |
32 |
$0.00 |
| 90739 |
|
13 |
12 |
$0.00 |
| 91301 |
|
26 |
26 |
$0.00 |
| 93000 |
|
31 |
24 |
$0.00 |
| J3490 |
Unclassified drugs |
83 |
81 |
$0.00 |
| 92551 |
|
50 |
41 |
$0.00 |
| A9150 |
Non-prescription drugs |
65 |
63 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
93 |
90 |
$0.00 |
| 91306 |
|
17 |
17 |
$0.00 |
| 3044F |
|
26 |
25 |
$0.00 |
| 90834 |
Psychotherapy, 45 minutes with patient |
30 |
29 |
$0.00 |